A randomized, phase 2 evaluation of the CHK1 inhibitor, LY2603618, administered in combination with pemetrexed and cisplatin in patients with advanced nonsquamous non‐small cell lung cancer
Titel:
A randomized, phase 2 evaluation of the CHK1 inhibitor, LY2603618, administered in combination with pemetrexed and cisplatin in patients with advanced nonsquamous non‐small cell lung cancer
Auteur:
Wehler, Thomas Thomas, Michael Schumann, Christian Bosch-Barrera, Joaquim Viñolas Segarra, Nuria Dickgreber, Nicolas J. Dalhoff, Klaus Sebastian, Martin Corral Jaime, Jesus Alonso, Miriam Hynes, Scott M. Lin, Ji Hurt, Karla Bence Lin, Aimee Calvo, Emiliano Paz-Ares, Luis